Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion
Leonid Timashev

Leonid Timashev Analyst Performance

Vice President, Biotechnology Analyst at Royal Bank Of Canada

Leonid Timashev is a stock analyst at Royal Bank Of Canada focused in the medical sector, covering 27 publicly traded companies. Over the past year, Leonid Timashev has issued 98 stock ratings, including buy and hold recommendations. While full access to Leonid Timashev's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Leonid Timashev's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
111 Last 1 Years
Buy Recommendations
87.39% 97 Buy Ratings
Companies Covered
27 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy87.4%97 ratings
Hold12.6%13 ratings
Sell0.0%0 ratings

Out of 111 total stock ratings issued by Leonid Timashev at Royal Bank Of Canada, the majority (87.4%) have been Buy recommendations, followed by 12.6% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
81.5% of companies on NASDAQ
22 companies
NYSE
14.8% of companies on NYSE
4 companies
NYSEAMERICAN
3.7% of companies on NYSEAMERICAN
1 company

Leonid Timashev, an analyst at Royal Bank Of Canada, currently covers 27 companies listed on NASDAQ, NYSE and NYSEAMERICAN, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
26 companies
96.3%
Consumer Staples
1 company
3.7%

Leonid Timashev of Royal Bank Of Canada specializes in stock coverage within the Medical sector, with additional focus on Consumer Staples companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
20 companies
74.1%
MED - DRUGS
4 companies
14.8%
MEDICAL SERVICES
1 company
3.7%
CONS PD - MISC STPL
1 company
3.7%
SURGICAL & MEDICAL INSTRUMENTS
1 company
3.7%

Leonid Timashev's Ratings History at Royal Bank Of Canada

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Jasper Therapeutics, Inc. stock logo
JSPR
Jasper Therapeutics
5/15/2026Set Price Target$0.82$3.00Sector Perform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
5/14/2026Boost Price Target$11.02$22.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
5/13/2026Boost Price Target$28.64$64.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
5/11/2026Boost Price Target$70.52$81.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
5/8/2026Lower Price Target$99.15$205.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
5/7/2026Boost Price Target$144.32$165.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
5/7/2026Boost Price Target$314.90$425.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
5/6/2026Boost Price Target$75.19$119.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/6/2026Boost Price Target$224.32$258.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/5/2026Boost Price Target$228.88$302.00Outperform
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
5/5/2026Reiterated Rating$3.77$6.00Outperform
Biohaven Ltd. stock logo
BHVN
Biohaven
5/5/2026Lower Price Target$9.37$22.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
5/5/2026Reiterated Rating$4.72$20.00Outperform
BRC Inc. stock logo
BRCC
BRC
5/5/2026Reiterated Rating$1.30$2.50Buy
CorMedix Inc stock logo
CRMD
CorMedix
4/28/2026Reiterated Rating$7.82$14.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
4/27/2026Boost Price Target$69.57$79.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
4/14/2026Boost Price Target$32.82$53.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
4/14/2026Boost Price Target$151.14$216.00Outperform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
3/18/2026Lower Price Target$4.63$7.00Sector Perform
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3/17/2026Lower Price Target$4.88$14.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
3/11/2026Lower Price Target$20.21$62.00Outperform
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
3/10/2026Boost Price Target$10.54$14.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
3/3/2026Boost Price Target$4.53$13.00Outperform
Biohaven Ltd. stock logo
BHVN
Biohaven
3/3/2026Boost Price Target$10.87$23.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
3/2/2026Lower Price Target$41.07$43.00Sector Perform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
2/26/2026Boost Price Target$322.37$425.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
2/26/2026Lower Price Target$30.33$45.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/25/2026Boost Price Target$192.05$195.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/24/2026Boost Price Target$170.33$222.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
2/20/2026Boost Price Target$67.66$101.00Outperform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
2/18/2026Boost Price Target$7.63$22.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
2/18/2026Reiterated Rating$30.75$49.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
2/11/2026Boost Price Target$42.01$46.00Sector Perform
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
1/23/2026Boost Price Target$7.40$21.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
1/21/2026Boost Price Target$6.00$12.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
1/21/2026Boost Price Target$32.41$47.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
1/21/2026Boost Price Target$163.51$200.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
1/21/2026Boost Price Target$35.75$45.00Outperform
CorMedix Inc stock logo
CRMD
CorMedix
1/21/2026Set Price Target$6.88$13.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
1/21/2026Boost Price Target$54.69$73.00Outperform
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/21/2026Boost Price Target$184.50$219.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
1/21/2026Reiterated Rating$64.68$95.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
1/20/2026Reiterated Rating$23.39$66.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
12/22/2025Boost Price Target$62.72$95.00Outperform
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
12/18/2025Lower Price Target$1.73$5.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
12/18/2025Lower Price Target$198.46$195.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
12/17/2025Reiterated Rating$307.91Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
12/8/2025Reiterated Rating$24.54$74.00Outperform
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
11/20/2025Upgrade$7.34$13.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
11/18/2025Boost Price Target$360.68$408.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
11/17/2025Set Price Target$170.34$194.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
11/17/2025Boost Price Target$41.01$61.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
11/13/2025Lower Price Target$31.39$74.00Outperform
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
11/11/2025Boost Price Target$63.66$87.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
11/7/2025Boost Price Target$314.09$395.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
11/7/2025Boost Price Target$17.30$50.00Outperform
Design Therapeutics, Inc. stock logo
DSGN
Design Therapeutics
11/6/2025Boost Price Target$6.46$6.00Sector Perform
Biohaven Ltd. stock logo
BHVN
Biohaven
11/6/2025Lower Price Target$8.44$9.00Sector Perform
Xencor, Inc. stock logo
XNCR
Xencor
11/6/2025Boost Price Target$14.61$19.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
11/6/2025Boost Price Target$37.24$44.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
11/6/2025Boost Price Target$133.08$155.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
11/4/2025Boost Price Target$4.78$8.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Boost Price Target$132.75$198.00Outperform
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
11/3/2025Initiated Coverage$58.84$77.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
10/31/2025Boost Price Target$192.36$215.00Outperform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
10/31/2025Reiterated Rating$8.76$11.00Sector Perform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
10/31/2025Downgrade$8.07$11.00Sector Perform
Xencor, Inc. stock logo
XNCR
Xencor
10/27/2025Boost Price Target$14.05$18.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
10/22/2025Boost Price Target$31.09$47.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
10/21/2025Boost Price Target$30.51$41.00Outperform
Exelixis, Inc. stock logo
EXEL
Exelixis
10/21/2025Reiterated Rating$35.17$45.00Sector Perform
Verastem, Inc. stock logo
VSTM
Verastem
10/20/2025Set Price Target$8.35$13.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
9/26/2025Upgrade$27.13$44.00Outperform
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
9/9/2025Boost Price Target$24.08$38.00Outperform
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/28/2025Boost Price Target$124.38$151.00Outperform
Xencor, Inc. stock logo
XNCR
Xencor
8/21/2025Lower Price Target$7.38$15.00Outperform
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
8/12/2025Reiterated Rating$37.38$77.00Outperform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
8/11/2025Set Price Target$7.57$27.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
8/8/2025Boost Price Target$109.19$120.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
8/8/2025Boost Price Target$12.76$49.00Outperform
Verastem, Inc. stock logo
VSTM
Verastem
8/8/2025Boost Price Target$6.79$13.00Outperform
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
8/8/2025Boost Price Target$2.37$7.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
8/7/2025Boost Price Target$22.71$39.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
8/7/2025Boost Price Target$296.70$364.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/5/2025Boost Price Target$106.54$189.00Outperform
Alkermes plc stock logo
ALKS
Alkermes
7/30/2025Boost Price Target$27.11$42.00Sector Perform
Exelixis, Inc. stock logo
EXEL
Exelixis
7/29/2025Lower Price Target$37.20$45.00Sector Perform
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
7/17/2025Lower Price Target$7.85$25.00Outperform
CG Oncology, Inc. stock logo
CGON
CG Oncology
7/16/2025Lower Price Target$25.36$53.00Outperform
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
7/16/2025Boost Price Target$276.52$349.00Outperform
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
7/9/2025Upgrade$21.45$30.00Moderate Buy
Verastem, Inc. stock logo
VSTM
Verastem
6/25/2025Upgrade$4.44$12.00Moderate Buy
CorMedix Inc stock logo
CRMD
CorMedix
6/20/2025Upgrade$13.76$17.00Moderate Buy
ADC Therapeutics SA stock logo
ADCT
ADC Therapeutics
6/20/2025Upgrade$3.07$5.00Moderate Buy
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
6/17/2025Upgrade$1.79$6.00Moderate Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
6/12/2025Lower Price Target$107.04$186.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
6/5/2025Reiterated Rating$14.25$48.00Outperform
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
6/3/2025Upgrade$3.21$16.00Moderate Buy
Biohaven Ltd. stock logo
BHVN
Biohaven
5/19/2025Downgrade$16.07$21.00Sector Perform
Biohaven Ltd. stock logo
BHVN
Biohaven
5/13/2025Lower Price Target$19.39$54.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
4/29/2025Boost Price Target$110.82$193.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
4/3/2025Lower Price Target$12.77$52.00Outperform
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
3/19/2025Reiterated Rating$1.07$8.00Outperform
BRC Inc. stock logo
BRCC
BRC
3/19/2025Reiterated Rating$2.12$3.00Buy
Alkermes plc stock logo
ALKS
Alkermes
3/13/2025Initiated Coverage$33.41$40.00Sector Perform
Biohaven Ltd. stock logo
BHVN
Biohaven
3/4/2025Reiterated Rating$30.42$61.00Outperform
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
3/4/2025Reiterated Rating$25.09$56.00Outperform
Insmed, Inc. stock logo
INSM
Insmed
2/25/2025Initiated Coverage$80.03$100.00Outperform
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/19/2025Boost Price Target$127.42$192.00Outperform
NewAmsterdam Pharma Company N.V. stock logo
NAMS
NewAmsterdam Pharma
1/24/2025Reiterated Rating$23.67$40.00Outperform
Incyte Corporation stock logo
INCY
Incyte
1/23/2025Reiterated Rating$72.24$70.00Sector Perform